Gastroenterology Research and Practice / 2012 / Article / Tab 1

Clinical Study

Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma

Table 1

Demographic features and outcomes of cytoreductive surgery in ten patients undergoing adjuvant chemotherapy with intraperitoneal pemetrexed and intravenous cisplatin for diffuse malignant peritoneal mesothelioma.

Number of patients

Total10
 Female3
 Male7
Age
 Mean51
 Range23–69
Peritoneal cancer index (PCI)
 Mean24
 Range7–39
CC score
 CC 0/14
 CC 24
 CC 32
Visceral sparing cytoreduction8
Colon resection2

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.